Graypoint LLC’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $748K | Sell |
1,924
-304
| -14% | -$118K | 0.04% | 258 |
|
2025
Q1 | $969K | Buy |
2,228
+658
| +42% | +$286K | 0.06% | 206 |
|
2024
Q4 | $579K | Sell |
1,570
-1,161
| -43% | -$428K | 0.04% | 278 |
|
2024
Q3 | $1.42M | Buy |
2,731
+256
| +10% | +$133K | 0.09% | 150 |
|
2024
Q2 | $1.34M | Buy |
2,475
+247
| +11% | +$134K | 0.09% | 148 |
|
2024
Q1 | $1.16M | Buy |
2,228
+247
| +12% | +$128K | 0.08% | 165 |
|
2023
Q4 | $934K | Buy |
1,981
+297
| +18% | +$140K | 0.08% | 174 |
|
2023
Q3 | $733K | Buy |
1,684
+193
| +13% | +$84K | 0.07% | 183 |
|
2023
Q2 | $662K | Sell |
1,491
-124
| -8% | -$55.1K | 0.07% | 181 |
|
2023
Q1 | $742K | Buy |
1,615
+536
| +50% | +$246K | 0.08% | 159 |
|
2022
Q4 | $554K | Sell |
1,079
-6
| -0.6% | -$3.08K | 0.07% | 178 |
|
2022
Q3 | $493K | Buy |
1,085
+358
| +49% | +$163K | 0.06% | 187 |
|
2022
Q2 | $351K | Buy |
727
+258
| +55% | +$125K | 0.05% | 225 |
|
2022
Q1 | $231K | Buy |
469
+31
| +7% | +$15.3K | 0.02% | 300 |
|
2021
Q4 | $203K | Buy |
+438
| New | +$203K | 0.02% | 292 |
|